Data / Form D filings / Spectrum Antimicrobials, Inc.
Spectrum Antimicrobials, Inc.: Form D filings
Spectrum Antimicrobials, Inc., a pharmaceuticals company in Petaluma, CA, filed 8 Form D notices with the SEC between 2020 and 2026. The latest, on April 1, 2026, reports $26.4 million sold of a $35 million offering to 247 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1770 CORPORATE CIRCLE, Petaluma, CA, 94954
- Phone
- (707) 668-7600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1808754
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Amendment | $35,000,000 | $26,385,000 | $8,615,000 | 247 | Mar 21, 2020 | sec.gov |
| Oct 22, 2024 | Amendment | $35,000,000 | $13,411,475 | $21,588,525 | 108 | Mar 21, 2020 | sec.gov |
| Sep 16, 2024 | New notice | $4,000,000 | $3,855,000 | $145,000 | 28 | Jul 25, 2022 | sec.gov |
| Sep 13, 2024 | Amendment | $35,000,000 | $13,111,475 | $21,888,525 | 105 | Mar 21, 2020 | sec.gov |
| Apr 1, 2022 | Amendment | $28,750,000 | $7,660,000 | $21,090,000 | 50 | Mar 21, 2020 | sec.gov |
| Apr 2, 2021 | Amendment | $28,750,000 | $5,040,000 | $23,710,000 | 26 | Mar 21, 2020 | sec.gov |
| Jun 10, 2020 | Amendment | $28,750,000 | $18,215,000 | $10,535,000 | 17 | Mar 21, 2020 | sec.gov |
| Apr 8, 2020 | New notice | $15,000,000 | $890,000 | $14,110,000 | 8 | Mar 21, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hojabr Alimi | Executive Officer, Director, Promoter | |
| Kate Lewis | Director | |
| William Henry Watson III | Executive Officer, Director, Promoter | |
| Steven Solferino | Director | |
| David Allie | Director | |
| Jerry Stonemetz | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Mar 30, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Spectrum Antimicrobials, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.